Education
About Us
Working with TipRanks
Follow Us
Zentalis Pharmaceuticals Inc (ZNTL)
:ZNTL
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 67.42M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 67.42M | $ -1.39M | $ -1.43M | $ -544.00K | $ -160.00K |
| Operating Income | $ -191.19M | $ -248.99M | $ -227.29M | $ -216.54M | $ -118.79M |
| EBITDA | $ -186.17M | $ -275.50M | $ -219.87M | $ -164.01M | $ -117.94M |
| Net Income | $ -165.84M | $ -292.19M | $ -220.83M | $ -164.26M | $ -118.55M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 351.91M | $ 482.92M | $ 437.37M | $ 339.89M | $ 338.50M |
| Total Assets | $ 430.34M | $ 551.69M | $ 539.31M | $ 454.51M | $ 365.56M |
| Total Debt | $ 39.58M | $ 43.15M | $ 45.17M | $ 45.91M | $ 2.00M |
| Net Debt | $ 5.68M | $ 15.11M | $ 2.10M | $ -13.80M | $ -52.95M |
| Total Liabilities | $ 93.15M | $ 114.30M | $ 105.29M | $ 90.03M | $ 32.18M |
| Stockholders' Equity | $ 337.19M | $ 437.28M | $ 434.02M | $ 364.48M | $ 333.38M |
| Cash Flow | |||||
| Free Cash Flow | $ -171.08M | $ -208.41M | $ -166.30M | $ -160.20M | $ -87.58M |
| Operating Cash Flow | $ -170.86M | $ -207.82M | $ -163.75M | $ -154.09M | $ -86.83M |
| Investing Cash Flow | $ 176.56M | $ -44.46M | $ -114.18M | $ -18.11M | $ -284.83M |
| Financing Cash Flow | $ 108.00K | $ 237.30M | $ 261.04M | $ 178.52M | $ 360.44M |